Sunny Song

Global Head of Business Development at Samyang Biopharm

Speaker

Sunny Song, PhD, MBA is a global business development, licensing, and strategic partnership leader with over 20 years of experience across biotech, pharma, and techbio. She has held senior roles at Fortune 500 R&D including Thermo Fisher, Danaher, and Agilent, as well as global GMP CDMO business development at WuXi Biologics, driving multimillion-dollar contracts and strategic alliances. Sunny has a strong track record in early-stage startup funding, business development, and cross-border partnerships across the U.S., China, India, and Korea. She currently leads global business development and licensing in New Therapeutics at Samyang Biopharm Corp., Samyang Group family (Korean conglomerate, $4B revenue) advancing growth through licensing, collaborations, and innovation-driven strategic partnerships